melatonin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
melatonin — no detected effect on pittsburgh Sleep Quality Index global score
Evidence strength: very limited.FindingNull result“There were no significant effects of melatonin on daytime sleepiness or sleep quality measured with ESS (p =.84) or PSQI (p =.11), respectively, but a small shift towards eveningness type was seen after melatonin treatment compared with placebo measured with MEQ (difference −2.3 [−3.7 to −0.9], p =.0036) (Table 4).”
Quoted verbatim from Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial.. - Study
- crossover
- Duration
- 3 months
- Dose
- 10 mg melatonin 1 h before bedtime for 12 weeks
- Population
- Seventeen men with type 2 diabetes on stable antidiabetic therapy; double-blind placebo-controlled crossover, measured on the study day at the end of each 12-week period; secondary endpoint
Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial.2022PMID:3561922110.1111/jpi.12809Permalink
To cite this finding: https://catalystproject.ai/e/01M5JVZXCRKAZM4K1KV26KYTC8